(Q45361142)

English

High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial

scientific article published on 28 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

based on heuristic

inferred from title

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Arne Kolstad

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

3

object named as

Mats Jerkeman

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Christian Geisler

5

object named as

Christian H Geisler

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

4

object named as

Riikka Räty

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Anna Laurell

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

publication date

28 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1206-1208

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.825906

21 January 2018

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.825906

21 January 2018

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.825906

21 January 2018

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.825906

21 January 2018

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.825906

21 January 2018

High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample stem cell harvest yields after multiple chemotherapy cycles

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.825906

21 January 2018

Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.825906

21 January 2018

Identifiers

10.3109/10428194.2013.825906

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45361142&oldid=2075835877"